BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 5:12:00 PM | Browse: 959 | Download: 661
Publication Name World Journal of Gastroenterology
Manuscript ID 5755
Country Israel
Received
2013-10-01 21:16
Peer-Review Started
2013-10-04 16:38
To Make the First Decision
2013-10-22 16:42
Return for Revision
2013-10-23 09:59
Revised
Second Decision
2014-04-23 08:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-23 09:59
Articles in Press
2014-05-23 11:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-28 22:47
Typeset the Manuscript
2014-07-03 18:37
Publish the Manuscript Online
2014-07-21 17:17
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Helicobacter pylori: Friend or foe?
Manuscript Source Invited Manuscript
All Author List Stephen David Howard Malnick, Ehud Melzer, Malka Attali, Gabriel Duek and Jacob Yahav
Funding Agency and Grant Number
Corresponding Author Stephen David Howard Malnick, Director, Department of Internal Medicine C, Kaplan Medical Center, PO Box 1, 76100 Rehovot, Israel. stephen@malnick.net
Key Words Helicobacter pylori; Treatment; Cost; Benefit; Cancer
Core Tip Helicobacter pylori (H. pylori) is found in more than half the world’s population. It is a major cause of peptic ulcer disease and gastric carcinoma. The overwhelming majority of those infected will not suffer any consequences during their lifetime. Furthermore, there may be a beneficial effect of H. pylori infection on allergy and asthma in young children and a protection against gastroesophageal reflux disease and its feared complication of esophageal carcinoma. Universal eradication will be prohibitively expensive, have adverse effects and needs to be evaluated on the basis of robust clinical data that is not yet available.
Publish Date 2014-07-21 17:17
Citation Malnick SDH, Melzer E, Attali M, Duek G, Yahav J. Helicobacter pylori: Friend or foe? World J Gastroenterol 2014; 20(27): 8979-8985
URL http://www.wjgnet.com/1007-9327/full/v20/i27/8979.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i27.8979
Full Article (PDF) WJG-20-8979.pdf
Full Article (Word) WJG-20-8979.doc
Manuscript File 5755-Review.docx
Answering Reviewers 5755-Answering reviewers.pdf
Copyright License Agreement 5755-Copyright assignment.pdf
Peer-review Report 5755-Peer reviews.pdf
Scientific Editor Work List 5755-Scientific editor work list.doc